It was a big day on the ASX on Wednesday headlined by a soaring pharmaceuticals share price and a new ASX tech listing.
Amidst the rough and tumble of domestic markets, here are 3 big things you might have missed in yesterday's trade.
1. Clinuvel share price rockets higher on FDA approval
The Clinuvel Pharmaceuticals Ltd (ASX: CUV) share price rocketed 60.2% higher yesterday after gaining a key regulatory approval in the United States.
The U.S. Food and Drug Administration (FDA) approved Clinuvel's SCENESSE treatment for a rare genetic metabolic disorder which causes a severe intolerance to light.
SCENESSE was approved by European regulators back in 2014 to treat erythropoietic protoporphyria (EPP). but the breakthrough to the lucrative U.S. market is big for Clinuvel.
Given the size of the U.S. pharmaceuticals market, the FDA approval should see Clinuvel revenues surge higher due to easier drug access for affected people.
2. Latest ASX tech IPO a big success
The latest Aussie tech stock to list on the ASX on Wednesday was robotic welding company K-TIG Ltd (ASX: KTG).
K-TIG is an Adelaide-based tech company that uses CSIRO-developed technology to weld up to 100 times faster than traditional welding processes.
With a strong bank of patents over the proprietary technology, K-TIG enjoyed a bumper first day on the ASX as its offer price tripled to close at $0.66 per share.
3. Cleanaway cleans up with latest acquisition
The Cleanaway Waste Management Ltd (ASX: CWY) share price closed 6.25% higher at $2.04 per share after announcing its latest acquisition.
Cleanaway announced it will acquire the assets of SKM Recycling Group following a public sale process conducted by company receivers.
The Aussie waste management company is set to pay $66 million for the SKM assets which saw bullish investors buy up big on Cleanaway shares yesterday.
